Remove providers pharmacy-retail-giant-walgreens-looks-disrupt-clinical-trials-business-it-builds
article thumbnail

July 2022 Semi-Annual Health IT Market Review

HIT Consultant

Further, when looking at 8-month trailing data (see the chart on page 3), valuations today continue to be ~70% higher compared to the 8-month trailing multiple from January 2018. In some respects, this will result in a healthy reduction in disruptive yet unsustainable strategic practices. Quality is at a premium.